Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney ...
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13,532.68 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback